These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q. Naia L; Ribeiro MJ; Rego AC Rev Neurosci; 2011 Dec; 23(1):13-28. PubMed ID: 22150069 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction. Mehan S; Monga V; Rani M; Dudi R; Ghimire K Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323 [TBL] [Abstract][Full Text] [Related]
4. Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease. Joshi AU; Ebert AE; Haileselassie B; Mochly-Rosen D J Mol Cell Cardiol; 2019 Feb; 127():125-133. PubMed ID: 30550751 [TBL] [Abstract][Full Text] [Related]
7. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies. Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802 [TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Antioxidants in Huntington's Disease: an Extensive Review. Essa MM; Moghadas M; Ba-Omar T; Walid Qoronfleh M; Guillemin GJ; Manivasagam T; Justin-Thenmozhi A; Ray B; Bhat A; Chidambaram SB; Fernandes AJ; Song BJ; Akbar M Neurotox Res; 2019 Apr; 35(3):739-774. PubMed ID: 30632085 [TBL] [Abstract][Full Text] [Related]
16. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Weydt P; Pineda VV; Torrence AE; Libby RT; Satterfield TF; Lazarowski ER; Gilbert ML; Morton GJ; Bammler TK; Strand AD; Cui L; Beyer RP; Easley CN; Smith AC; Krainc D; Luquet S; Sweet IR; Schwartz MW; La Spada AR Cell Metab; 2006 Nov; 4(5):349-62. PubMed ID: 17055784 [TBL] [Abstract][Full Text] [Related]
17. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Seong IS; Ivanova E; Lee JM; Choo YS; Fossale E; Anderson M; Gusella JF; Laramie JM; Myers RH; Lesort M; MacDonald ME Hum Mol Genet; 2005 Oct; 14(19):2871-80. PubMed ID: 16115812 [TBL] [Abstract][Full Text] [Related]
20. Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease. Tobore TO J Neurosci Res; 2019 Nov; 97(11):1455-1468. PubMed ID: 31304621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]